|
|
|
Volumn 24, Issue 1 SUPPL. 2, 1997, Pages
|
|
Phase I trial of paclitaxel/carboplatin in advanced carcinoma of the urothelium
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
PACLITAXEL;
ANTINEOPLASTIC AGENT;
ADULT;
ADVANCED CANCER;
AGED;
AREA UNDER THE CURVE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
FEMALE;
GRANULOCYTOPENIA;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MAXIMUM PERMISSIBLE DOSE;
NEUROPATHY;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
UROGENITAL TRACT TUMOR;
ARTICLE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
MIDDLE AGED;
PHASE 1 CLINICAL TRIAL;
URINARY TRACT CANCER;
UROTHELIUM;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AREA UNDER CURVE;
CARBOPLATIN;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PACLITAXEL;
UROLOGIC NEOPLASMS;
UROTHELIUM;
|
|
EID: 0031065242
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (15)
|
|
References (5)
|
